Remdesivir, HCQ have no antiviral effects: WHO study
The researchers found that Remdesivir and HCQ did not affect the degree of respiratory failure or inflammation.
The researchers found that Remdesivir and HCQ did not affect the degree of respiratory failure or inflammation.
According to information available on the internet, ‘Remivir 100’ is the brand name of the Remdesivir injection produced by Bangladeshi pharmaceutical company ‘Eskayef Pharmaceuticals’.
According to hospital authorities, the injection vials had been provided by the district administration on Friday and they had to be administered to the patients today.
